Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
Our Company

The New York Times, Pre-Emption and ORTHO EVRA

Today's Top Reads Close

Yesterday, The New York Times published an article entitled, “Drug Makers Near Old Goal: A Legal Shield.” The article is primarily about a legal doctrine called pre-emption, but ORTHO EVRA®, the birth control patch marketed in the U.S. by our Ortho-McNeil unit is prominently featured. For those interested, my colleagues at Ortho McNeil have published their position on this article on their website.

Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.